CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved

Antisense and Nucleic Acid Drug Development

Volumn 11, Issue 5, 2001, Pages 333-340

  Rankin, R ^a,b   Pontarollo, R ^a   Ioannou, X ^a   Krieg, A M ^b,c   Hecker, R ^d   Babiuk, L A ^a   Van Drunen Littel van den Hurk, S ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b PFIZER INC   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d QIAGEN GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE;

ARTICLE; CELL PROLIFERATION; CPG ISLAND; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; MOLECULAR RECOGNITION; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEQUENCE ANALYSIS; SHEEP; VERTEBRATE; VETERINARY MEDICINE;

ANIMALIA; MURINAE; ORYCTOLAGUS CUNICULUS; OVIS ARIES; VERTEBRATA;

EID: 0035187324     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729001753231713     Document Type: Article

References (35)

1. Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
2. Experimental infection of sheep with a rabies virus of canine origin: Study of the pathogenicity for that species
3. Compatibility of plasmids expressing different antigens in a single DNA vaccine formulation
4. DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells
5. Detection of specific T cell reactivity in sheep infected with Mycobacterium avium subspecies silvaticum and paratuberculosis using two defined mycobacterial antigens
6. Pervasive CpG suppression in animal mitochondrial genomes
7. Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice
8. Bacterial DNA-induced NK cell IFNγ production is dependent on macrophage secretion of IL-12
9. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
10. Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides
11. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
12. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
13. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo
14. A toll-like receptor recognizes bacterial DNA
15. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys
16. Mammalian granulocyte-macrophage colony-stimulating factor and some CpG motifs have an effect on the immunogenicity of DNA and subunit vaccines in fish
17. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma
18. Therapeutic applications of CpG-containing oligodeoxynucleotides
19. The role of CpG motifs in innate immunity
20. CpG motifs in bacterial DNA trigger direct B-cell activation
21. The role of CpG dinucleotides in DNA vaccines
22. Production and characterization of bovine herpesvirus-1 glycoprotein ectodomain derivatives in an hsp70A gene promoter-based expression system
23. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants
24. Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle
25. Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis
26. CpG DNA, a novel immune enhancer for systemic and mucosal immunisation with influenza virus
27. Bovine respiratory syncytial virus protects cotton rats against human respiratory syncytial virus infection
28. Immune responses of lambs experimentally infected with bovine respiratory syncytial virus and Pasteurella haemolytica
29. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
30. Type 1 interferon-mediated stimulation of T cells by CpG DNA
31. A subunit gIV vaccine, produced by transected mammalian cells in culture, induces mucosal immunity in cattle
32. CpG DNA induces stronger immune responses with less toxicity than other adjuvants
33. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma
34. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry